Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean McBride

Showing results (81-90 of 98) with videos related to

Pageof 10
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 15, 2021
Predictors for post-treatment biopsy outcomes after prostate stereotactic body radiotherapyMichael J Zelefsky, Debra A Goldman, Margaret Hopkins, et al.
International Journal of Radiation Oncology, Biology, Physics|February 19, 2024
Clinical Experience With an Offline Adaptive Radiation Therapy Head and Neck Program: Dosimetric Benefits and Opportunities for Patient SelectionMichalis Aristophanous, Eric Aliotta, Phillip Lichtenwalner, et al.
International Journal of Radiation Oncology, Biology, Physics|March 23, 2021
A Multi-Institutional Phase 2 Trial of High-Dose SAbR for Prostate Cancer Using Rectal SpacerMichael R Folkert, Michael J Zelefsky, Raquibul Hannan, et al.
International Journal of Radiation Oncology, Biology, Physics|April 15, 2026
Dosimetric Results for Organs at Risk from Radiotherapy Dose De-Escalation to the Subclinical Region in HPV-Mediated Oropharyngeal Cancer: A Propensity Score-Matched AnalysisDavid Gibbes Miller, Irini Yacoub, Eric Aliotta, et al.
Prostate Cancer and Prostatic Diseases|December 4, 2023
Major adverse cardiovascular events of enzalutamide versus abiraterone in prostate cancer: a retrospective cohort studyYan Hiu Athena Lee, Jeremy Man Ho Hui, Chi Ho Leung, et al.
Head & Neck|July 12, 2019
Timing of surgery and adjuvant radiation therapy for sinonasal malignancies: Effect of surgical approachRoy Xiao, Rohan R Joshi, Qasim Husain, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 22, 2020
Randomized Phase II Trial of Nivolumab With Stereotactic Body Radiotherapy Versus Nivolumab Alone in Metastatic Head and Neck Squamous Cell CarcinomaSean McBride, Eric Sherman, C Jillian Tsai, et al.
International Journal of Radiation Oncology, Biology, Physics|August 12, 2016
Strategy of Using Intratreatment Hypoxia Imaging to Selectively and Safely Guide Radiation Dose De-escalation Concurrent With Chemotherapy for Locoregionally Advanced Human Papillomavirus-Related Oropharyngeal CarcinomaNancy Lee, Heiko Schoder, Brad Beattie, et al.
Thyroid : Official Journal of the American Thyroid Association|August 15, 2018
Intensity-Modulated Radiation Therapy With or Without Concurrent Chemotherapy in Nonanaplastic Thyroid Cancer with Unresectable or Gross Residual DiseaseThomas H Beckham, Paul B Romesser, Andries H Groen, et al.
Cancer|October 9, 2019
Outcomes of multimodal therapy in a large series of patients with anaplastic thyroid cancerDan Fan, Jennifer Ma, Andrew C Bell, et al.
Pageof 10

Showing results (81-90 of 98) with videos related to

Sort By:
Pageof 10
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 15, 2021
Predictors for post-treatment biopsy outcomes after prostate stereotactic body radiotherapyMichael J Zelefsky, Debra A Goldman, Margaret Hopkins, et al.
International Journal of Radiation Oncology, Biology, Physics|February 19, 2024
Clinical Experience With an Offline Adaptive Radiation Therapy Head and Neck Program: Dosimetric Benefits and Opportunities for Patient SelectionMichalis Aristophanous, Eric Aliotta, Phillip Lichtenwalner, et al.
International Journal of Radiation Oncology, Biology, Physics|March 23, 2021
A Multi-Institutional Phase 2 Trial of High-Dose SAbR for Prostate Cancer Using Rectal SpacerMichael R Folkert, Michael J Zelefsky, Raquibul Hannan, et al.
International Journal of Radiation Oncology, Biology, Physics|April 15, 2026
Dosimetric Results for Organs at Risk from Radiotherapy Dose De-Escalation to the Subclinical Region in HPV-Mediated Oropharyngeal Cancer: A Propensity Score-Matched AnalysisDavid Gibbes Miller, Irini Yacoub, Eric Aliotta, et al.
Prostate Cancer and Prostatic Diseases|December 4, 2023
Major adverse cardiovascular events of enzalutamide versus abiraterone in prostate cancer: a retrospective cohort studyYan Hiu Athena Lee, Jeremy Man Ho Hui, Chi Ho Leung, et al.
Head & Neck|July 12, 2019
Timing of surgery and adjuvant radiation therapy for sinonasal malignancies: Effect of surgical approachRoy Xiao, Rohan R Joshi, Qasim Husain, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 22, 2020
Randomized Phase II Trial of Nivolumab With Stereotactic Body Radiotherapy Versus Nivolumab Alone in Metastatic Head and Neck Squamous Cell CarcinomaSean McBride, Eric Sherman, C Jillian Tsai, et al.
International Journal of Radiation Oncology, Biology, Physics|August 12, 2016
Strategy of Using Intratreatment Hypoxia Imaging to Selectively and Safely Guide Radiation Dose De-escalation Concurrent With Chemotherapy for Locoregionally Advanced Human Papillomavirus-Related Oropharyngeal CarcinomaNancy Lee, Heiko Schoder, Brad Beattie, et al.
Thyroid : Official Journal of the American Thyroid Association|August 15, 2018
Intensity-Modulated Radiation Therapy With or Without Concurrent Chemotherapy in Nonanaplastic Thyroid Cancer with Unresectable or Gross Residual DiseaseThomas H Beckham, Paul B Romesser, Andries H Groen, et al.
Cancer|October 9, 2019
Outcomes of multimodal therapy in a large series of patients with anaplastic thyroid cancerDan Fan, Jennifer Ma, Andrew C Bell, et al.
Pageof 10